Latest filing published 13 Jul 2023 for IVERIC bio, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Keith Westby is a declared insider of IVERIC bio, Inc. (chief executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 9 December 2021 to 11 July 2023, the count stands at 25 filings.
Every open-market trade on record is a sale: 7 sales worth €1.5M. Outside the open market, there are 17 option exercises. 2023 to date brings no purchases and 1 sale.
The newest entry dates from 13 July 2023: a transaction, in IVERIC bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations